180 related articles for article (PubMed ID: 37445934)
21. Involvement of endogenously produced 1,25-dihydroxyvitamin D-3 in the growth and differentiation of human keratinocytes.
Matsumoto K; Azuma Y; Kiyoki M; Okumura H; Hashimoto K; Yoshikawa K
Biochim Biophys Acta; 1991 May; 1092(3):311-8. PubMed ID: 1646640
[TBL] [Abstract][Full Text] [Related]
22. Brk protects breast cancer cells from autophagic cell death induced by loss of anchorage.
Harvey AJ; Pennington CJ; Porter S; Burmi RS; Edwards DR; Court W; Eccles SA; Crompton MR
Am J Pathol; 2009 Sep; 175(3):1226-34. PubMed ID: 19661439
[TBL] [Abstract][Full Text] [Related]
23. Putting the BRK on breast cancer: From molecular target to therapeutics.
Ang HL; Yuan Y; Lai X; Tan TZ; Wang L; Huang BB; Pandey V; Huang RY; Lobie PE; Goh BC; Sethi G; Yap CT; Chan CW; Lee SC; Kumar AP
Theranostics; 2021; 11(3):1115-1128. PubMed ID: 33391524
[TBL] [Abstract][Full Text] [Related]
24. Tracing the footprints of the breast cancer oncogene BRK - Past till present.
Goel RK; Lukong KE
Biochim Biophys Acta; 2015 Aug; 1856(1):39-54. PubMed ID: 25999240
[TBL] [Abstract][Full Text] [Related]
25. BRK targets Dok1 for ubiquitin-mediated proteasomal degradation to promote cell proliferation and migration.
Miah S; Goel RK; Dai C; Kalra N; Beaton-Brown E; Bagu ET; Bonham K; Lukong KE
PLoS One; 2014; 9(2):e87684. PubMed ID: 24523872
[TBL] [Abstract][Full Text] [Related]
26. HER2 regulates Brk/PTK6 stability via upregulating calpastatin, an inhibitor of calpain.
Ai M; Qiu S; Lu Y; Fan Z
Cell Signal; 2013 Sep; 25(9):1754-61. PubMed ID: 23707532
[TBL] [Abstract][Full Text] [Related]
27. Brk/PTK6 signaling in normal and cancer cell models.
Ostrander JH; Daniel AR; Lange CA
Curr Opin Pharmacol; 2010 Dec; 10(6):662-9. PubMed ID: 20832360
[TBL] [Abstract][Full Text] [Related]
28. BRK phosphorylates PSF promoting its cytoplasmic localization and cell cycle arrest.
Lukong KE; Huot ME; Richard S
Cell Signal; 2009 Sep; 21(9):1415-22. PubMed ID: 19439179
[TBL] [Abstract][Full Text] [Related]
29. Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells.
Miah S; Bagu E; Goel R; Ogunbolude Y; Dai C; Ward A; Vizeacoumar FS; Davies G; Vizeacoumar FJ; Anderson D; Lukong KE
BMC Cancer; 2019 Jan; 19(1):78. PubMed ID: 30651078
[TBL] [Abstract][Full Text] [Related]
30. Squamous carcinoma cell lines fail to respond to 1,25-Dihydroxyvitamin D despite normal levels of the vitamin D receptor.
Ratnam AV; Bikle DD; Su MJ; Pillai S
J Invest Dermatol; 1996 Mar; 106(3):522-5. PubMed ID: 8648187
[TBL] [Abstract][Full Text] [Related]
31. Breast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast Cancer.
Regan Anderson TM; Ma SH; Raj GV; Cidlowski JA; Helle TM; Knutson TP; Krutilina RI; Seagroves TN; Lange CA
Cancer Res; 2016 Mar; 76(6):1653-63. PubMed ID: 26825173
[TBL] [Abstract][Full Text] [Related]
32. 20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation.
Zbytek B; Janjetovic Z; Tuckey RC; Zmijewski MA; Sweatman TW; Jones E; Nguyen MN; Slominski AT
J Invest Dermatol; 2008 Sep; 128(9):2271-80. PubMed ID: 18368131
[TBL] [Abstract][Full Text] [Related]
33. Vitamin D May Protect against Breast Cancer through the Regulation of Long Noncoding RNAs by VDR Signaling.
Blasiak J; Chojnacki J; Pawlowska E; Jablkowska A; Chojnacki C
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328609
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a vitamin D3-resistant MCF-7 cell line.
Narvaez CJ; Vanweelden K; Byrne I; Welsh J
Endocrinology; 1996 Feb; 137(2):400-9. PubMed ID: 8593782
[TBL] [Abstract][Full Text] [Related]
35. Production of 22-hydroxy metabolites of vitamin d3 by cytochrome p450scc (CYP11A1) and analysis of their biological activities on skin cells.
Tuckey RC; Li W; Shehabi HZ; Janjetovic Z; Nguyen MN; Kim TK; Chen J; Howell DE; Benson HA; Sweatman T; Baldisseri DM; Slominski A
Drug Metab Dispos; 2011 Sep; 39(9):1577-88. PubMed ID: 21677063
[TBL] [Abstract][Full Text] [Related]
36. 1,25-Dihydroxyvitamin D3 potentiates the keratinocyte response to calcium.
Su MJ; Bikle DD; Mancianti ML; Pillai S
J Biol Chem; 1994 May; 269(20):14723-9. PubMed ID: 7910167
[TBL] [Abstract][Full Text] [Related]
37. BRK confers tamoxifen-resistance in breast cancer via regulation of tyrosine phosphorylation of CDK1.
Mandapati A; Ning Z; Baharani A; Lukong KE
Cell Signal; 2023 Aug; 108():110723. PubMed ID: 37216999
[TBL] [Abstract][Full Text] [Related]
38. Cancer-Associated Mutations in Breast Tumor Kinase/PTK6 Differentially Affect Enzyme Activity and Substrate Recognition.
Tsui T; Miller WT
Biochemistry; 2015 May; 54(20):3173-82. PubMed ID: 25940761
[TBL] [Abstract][Full Text] [Related]
39. Taxol Induces Brk-dependent Prosurvival Phenotypes in TNBC Cells through an AhR/GR/HIF-driven Signaling Axis.
Regan Anderson TM; Ma S; Perez Kerkvliet C; Peng Y; Helle TM; Krutilina RI; Raj GV; Cidlowski JA; Ostrander JH; Schwertfeger KL; Seagroves TN; Lange CA
Mol Cancer Res; 2018 Nov; 16(11):1761-1772. PubMed ID: 29991529
[TBL] [Abstract][Full Text] [Related]
40. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.
Wietzke JA; Welsh J
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):149-57. PubMed ID: 12710998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
